ISPOR 2026
Sunday, May 17 - Wednesday, May 20
-
IMPACT OF EMERGENCY DEPARTMENT (ED) INVOLVEMENT AT CANCER DIAGNOSIS ON HEALTHCARE COSTS (HCC) ACROSS CANCER TYPES IN THE MEDICARE POPULATION
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF LENACAPAVIR VERSUS ORAL AND INJECTABLE PREP OPTIONS FOR HIV PREVENTION IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
GLOBAL ASSESSMENT OF THE DIAGNOSED PREVALENCE OF CROHN’S DISEASE AND ULCERATIVE COLITIS IN PEDIATRIC POPULATIONS
Mar 18, 2026, 21:38 PM -
TEMPORAL TRENDS AND PREDICTORS OF FIRST-LINE CHEMOTHERAPY AMONG OLDER WOMEN DIAGNOSED WITH TRIPLE-NEGATIVE BREAST CANCER IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
INCLUSIVE HEALTH RESEARCH IN THE PALM OF YOUR HAND: THE EVIDATION EVERYONE REGISTRY
Mar 18, 2026, 21:38 PM -
STREAMLINING KIDNEY TRANSPLANT COORDINATION THROUGH PROCESS MAPPING: IMPROVING TIMELINESS, REGULATORY COMPLIANCE, AND ORGAN UTILISATION IN A TERTIARY HOSPITAL
Mar 18, 2026, 21:38 PM -
ACCESS TO CARE, QUALITY OF LIFE AND MENTAL HEALTH SERVICE UTILIZATION AMONG US ADULTS WITH DEPRESSION
Mar 18, 2026, 21:38 PM -
REAL-WORLD EFFICACY OF AUMOLERTINIB IN PATIENTS WITH ADVANCED EGFR T790M-POSITIVE NON-SMALL CELL LUNG CANCER: A MULTICENTRE RETROSPECTIVE COHORT STUDY IN JIANGSU PROVINCE, CHINA
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS ANALYSIS OF BIREOCICLIB VERSUS ABEMACICLIB IN HR+/HER2- ADVANCED OR METASTATIC BREAST CANCER: COMPARING MATCHING-ADJUSTED INDIRECT COMPARISON AND SIMULATED TREATMENT COMPARISON APPROACHES
Mar 18, 2026, 21:38 PM -
TRENDS IN SPECIALTY DRUG COVERAGE POLICY COMPLEXITY AMONG US COMMERCIAL HEALTH PLANS
Mar 18, 2026, 21:38 PM -
PREDICTING CANCER’S NEXT MOVE AFTER LOCAL/REGIONAL RECURRENCE (LR) FOR HEALTH ECONOMIC EVALUATIONS: A PAN-TUMOR CASE STUDY
Mar 18, 2026, 21:38 PM -
TREATMENT PATTERNS AND GAPS IN RESECTABLE MUCOSAL MELANOMA CARE FOR MEDICARE BENEFICIARIES IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
ASSESSING HEALTH SERVICE VARIATIONS BY DEGREE OF URBANIZATION IN NEPAL
Mar 18, 2026, 21:38 PM -
DISTINCT CARE PATHWAYS AND ECONOMIC IMPACT IN TREATED GEP-NET: A U.S. CLAIMS ANALYSIS OF METASTATIC VS NON-METASTATIC DISEASE
Mar 18, 2026, 21:38 PM -
THE DIVERSITY OF HEALTH ACCESS IN THE US: A GEOSPATIAL ANALYSIS OF INTEGRATED DELIVERY NETWORKS AND AFFILIATED MEDICARE PROVIDERS
Mar 18, 2026, 21:38 PM -
FRAMEWORK FOR RWD TRANSFORMATIONS FROM NATIVE DATA MODELS TO CDISC DATA STANDARDS
Mar 18, 2026, 21:38 PM -
RESHAPING ALLERGY ASSESSMENT PATHWAYS IN THE UNITED KINGDOM TO IMPROVE ACCESS, CAPACITY, AND VALUE: A DISCRETE EVENT SIMULATION
Mar 18, 2026, 21:38 PM -
HEALTHCARE RESOURCE UTILIZATION WITH RECOMBINANT ADAMTS13 IN PATIENTS WITH CONGENITAL TTP: RESULTS FROM A PHASE 3 RANDOMIZED CLINICAL TRIAL
Mar 18, 2026, 21:38 PM -
REAL-WORLD FRONT-LINE USE OF ENFORTUMAB VEDOTIN - PEMBROLIZUMAB (EV+P) AFTER ADJUVANT NIVOLUMAB IN ADVANCED UROTHELIAL CANCER(AUC)
Mar 18, 2026, 21:38 PM -
ASSESSING PRIORITIES IN ETHNICALLY DIVERSE CAREGIVERS FOR PEOPLE WITH AGITATION IN ALZHEIMER'S DEMENTIA
Mar 18, 2026, 21:38 PM